
A meta-analysis presented at IDWeek 2026 found responses were stronger after chemotherapy but waned within a year, supporting a 2-dose strategy.
Doug Long, vice president of industry relations at IMS Health, discusses his predictions for the 2012-2013 flu season.
In this video, Doug Long, vice president of industry relations at IMS Health, discusses his predictions for the 2012-2013 flu season.






